Active16057274Private limited companyCambridge

GXP PHARMA LIMITED

Significant control: Dolster Limited (75–100%)

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Gxp Pharma Limited: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Gxp Pharma Limited sell?

Registered activity: Manufacture of pharmaceutical preparations (SIC 21200). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01

Summary

Generated from filed data · no estimates

GXP PHARMA LIMITED is an active private limited company (company number 16057274) incorporated on 4 November 2024, registered in Cambridge. Its registered activity is manufacture of pharmaceutical preparations (SIC 21200). Latest small accounts cover the period ending 30 September 2025, showing net assets of −£5,236 and cash of £17k, with 0 employees on average.

Peer position · net assets

By net assets it sits in the bottom quarter of 307 comparable companies in the UK (median £1,000, upper quartile £146k).

02

Ownership and control

1 active
  • Dolster Limited
    corporate entity, United Kingdom · since 4 November 2024
    • owns 75–100% of shares
    • holds 75–100% of voting rights
    • can appoint or remove directors

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

03

Key dates

Incorporated
4 November 20241 yr ago
Next accounts due
30 June 2027in 249 days
Confirmation statement due
18 November 2026in 25 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

04

Activity

SIC 21200
Manufacture of pharmaceutical preparations
SIC 46460
Wholesale of pharmaceutical goods
SIC 72110
Research and experimental development on biotechnology
SIC 74909
Other professional, scientific and technical activities n.e.c.
Accounts type
Total Exemption Full
Size band
MicroCompanies Act thresholds
05

Financials

1 period on record · latest ending 30 September 2025
Net assets
−£5,236
1 period on record
Cash at bank
£17k
1 period on record
Turnover
Not reported
Employees
0
1 period on record
Filed accounts by period, newest first
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
30 September 2025−£5,236£17k£1,840£26k——0
Current ratio0.73Current assets ÷ creditors within one year

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

06

Filing and accounts signals

Facts from the register · no rating
  • Net assets below zeroNet assets £-5,236 at 30 September 2025
  • Current assets below creditors within one yearCurrent ratio 0.73
  • Incorporated less than two years agoIncorporated 4 November 2024; no accounts due yet

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

07

Timeline

Newest first
  1. Next accounts duein 249 days
  2. Confirmation statement duein 25 days
  3. Accounts period endNet liabilities £5,236 · small accounts
  4. Incorporated
08

Similar companies in Cambridge

Same activity (manufacture of pharmaceutical preparations), closest in incorporation date
09

Reminders for GXP PHARMA LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31; accounts from the Companies House accounts data product. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown.